BP904

乙酰唑胺

British Pharmacopoeia (BP) Reference Standard

• 别名: 5-乙酰胺基-1,3,4-噻二唑-2-磺酰胺, N-（5-[氨基磺酰基]-1,3,4-噻二唑-2-基）乙酰胺, N-（5-氨磺酰基-1,3,4-噻二唑-2-基）乙酰胺
• 经验公式（希尔记法）: C₄H₆N₄O₃S₂
• CAS号: 59-66-5
• 分子量: 222.25
• MDL號碼: MFCD00003105
• 分類程式碼代碼: 41116107
• NACRES: NA.24

属性

• 等級: pharmaceutical primary standard
• API 家族: acetazolamide
• 形狀: solid
• 儲存期限: limited shelf life, expiry date on the label
• 製造商／商標名: BP
• 應用: pharmaceutical; pharmaceutical small molecule
• 格式: neat
• 儲存溫度: 2-8°C
• SMILES 字串: CC(=O)Nc1nnc(s1)S(N)(=O)=O
• InChI: 1S/C4H6N4O3S2/c1-2(9)6-3-7-8-4(12-3)13(5,10)11/h1H3,(H2,5,10,11)(H,6,7,9)
• InChI 密鑰: BZKPWHYZMXOIDC-UHFFFAOYSA-N
• 基因資訊: human ... CA1(759) , CA12(771) , CA2(760) , CA4(762)

说明

一般說明

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

應用

Acetazolamide BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:

Acetazolamide Oral Suspension

碳酸酐酶抑制剂；增加脑血流量。

生化／生理作用

通过与水通道蛋白相互作用抑制膜的水渗透性

包裝

Unit quantity: 600 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

其他說明

Sales restrictions may apply.

安全信息

• 象形圖: GHS07
• 訊號詞: Warning
• 危險聲明: H315,H319
• 防範說明: P264 - P280 - P302 + P352 - P332 + P313 - P337 + P313 - P362 + P364
• 危險分類: Eye Irrit. 2 - Skin Irrit. 2
• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 2
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable